Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Relmada Therapeutics
Biotech
Relmada reconsiders plans to test psilocybin for obesity
Relmada’s attempts to see whether a magic mushroom extract could be used to treat obesity may be coming to an end before they really began.
James Waldron
Mar 28, 2025 10:00am
Struggling Relmada pays $3M for Tourette's asset from Asarina
Feb 7, 2025 11:00am
After 3rd phase 3 strike, Relmada's depression drug is out
Dec 9, 2024 2:30pm
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Relmada's depression med bounces back in open-label trial
Sep 20, 2023 11:00am
After phase 3 flops, Relmada plots depression drug comeback
Mar 24, 2023 5:51am